Rheumatoid Arthritis

A recent study investigated whether an anabolic agent could improve joint damage caused by erosive rheumatoid arthritis in patients treated with a tumor necrosis factor inhibitor.

A recent study investigated whether an anabolic agent could improve joint damage caused by erosive rheumatoid arthritis in patients treated with a tumor necrosis factor inhibitor.

After successful testing, a new treatment for rheumatoid arthritis has been approved by the US Food and Drug Administration.

In a recent study, researchers aimed to quantify the impact of RA pharmacotherapy on mental and physical health outcomes.

In a recent study, researchers aimed to quantify the impact of RA pharmacotherapy on mental and physical health outcomes.

A recent study examined the impact of a nation-wide, non-medical switch from originator to biosimilar on disease activity and retention rates among patients with rheumatoid arthritis, psoriatic arthritis,...

A recent study examined associations between cause-specific mortality, including cancer, and weight loss and body mass index in men with rheumatoid arthritis.

Early treatment for rheumatoid arthritis (RA) is associated with improved long-term outcomes and mortality risk compared with later treatment.

Early treatment for rheumatoid arthritis (RA) is associated with improved long-term outcomes and mortality risk compared with later treatment.

A study aimed to quantify the risk of liver damage at varying levels of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.